💨 Abstract
Remedium Lifecare Limited, a pharmaceutical intermediates and specialty chemicals manufacturer, has received BSE approval for its proposed rights issue. The issue aims to raise growth capital, strengthening its financial foundation and supporting strategic initiatives like expansion and market penetration. The rights issue size is Rs4,919.04 Lakhs, with a record date on April 15, 2025, and a price per share of Rs1.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Supreme Group strengthens Thailand presence with full ownership of Supreme Feltol; unveils new identity Supreme Fostreon (Thailand) Company Limited
Dhirubhai Ambani Honoured Posthumously With 'Lifetime Achievment Award'
AI for Ocean is not just a research theme, it's a mission for the future of humanity": Dr. V. Kamakoti, Director - IIT Madras
Europeans, Ukrainians make their case as Rubio and Witkoff visit Paris
MetaApplyIE Comprehensive Career Counselling Expertise to Empower Students' Futures
Innovation Emerges as Top Priority for Indo-French Companies at the 7th Edition of the Indo-French Business Awards 2025 & Grand Prix VIE
Manav Rachna International School, Sector 46, Gurugram Introduces IB Curriculum for Early to Middle Years
Crompton Strengthens Commitment to Green Energy with Solar Water Pump Order from MEDA
Italy says to meet NATO's 2% of GDP defence spending goal this year
What is the most common cause of fluid retention and how it affects your blood pressure?
Powered by MessengerX.io